Original from: mddionline
Author: Daphne Allen
Image Credit: JHVEPhoto ¨C Adobe Stock
¡°Our efforts push on two prongs¡ªinnovation and safety, which we believe are two sides of the same coin,¡± Shuren shared as he kicked off the session. He added that such work includes ¡°derisking the entire product lifecycle such that the development of and investment in medical devices and the U.S. marketplace is far more attractive.¡±
Understandably, COVID-19 still is ¡°the top effort underway at the center,¡± he said, adding that they¡¯ve seen a "massive increase in submissions and a big increase in workload." For instance, in 2020, the center saw a 38% increase in submissions, and it has brought almost 1700 medical devices to authorization in the United States, he said. ¡°Critical to that was the regulatory flexibility of EUAs and extensive engagement with developers,¡± he added.
Click the following link to read the slideshow for updates on key CDRH projects. And be sure to click through to the end for a flashback to last year's CDRH Townhall.
https://www.mddionline.com/regulations/11-fda-plans-you-need-know-about/gallery?slide=1